. Toxicol. Sci. 45,[152][153][154][155][156][157][158][159][160][161] The dose responses for several effects of low-level limited exposures to 2-acetylaminofluorene (AAF) in the livers of male Fischer 344 rats were measured and a subsequent phenobarbital tumor promotion regimen was used to manifest initiation of carcinogenesis. Three doses over a 10-fold range yielding cumulative total exposures of 0.126,0.42, and 1.26 mmol AAF/kg body weight were achieved by daily intragastric instillation for up to 12 weeks with interim terminations. This was followed by 24 weeks administration of 500 ppm phenobarbital (PB) in the diet to promote liver tumor development. At 12 weeks at the end of AAF administration, all exposures produced adducts in liver DNA, measured by 32 P postlabeling, and the level of adducts increased with exposure, except that the high exposure did not produce a dose proportional increase. Measurement of arylsutfotransferase activity, a key enzyme in the metabolic activation of AAF, revealed that in livers from the high exposure animals, the enzyme was inhibited. To assess for toxicity, the centrilobular zone of glutamine synthetasepositive hepatocytes was quantified immunohistochemically at 12 weeks. The area of the zone was reduced in the high exposure group and there was a trend to reduction in relationship to exposure. The two lower exposures to AAF produced no increase in cell proliferation, whereas the high exposure resulted in a marked increase, about 8-fold over controls. Initiation was assessed by induction of hepatocellular altered foci (HAF) that expressed the placental form of glutathione 5-transferase. AAF induced HAF in the high exposure group, 9-fold at 8 weeks and 170-fold at 12 weeks compared to controls. In rats maintained on PB for 24 weeks after exposure, the multiplicity of HAF increased in controls and comparably in the low and mid exposure groups, but remained at the about the same high level in the high exposure group. The high exposure produced a substantial incidence of benign neoplasms by 12 weeks, and with promotion by 36 weeks, all rats developed hepatocellular neoplasia. In the mid exposure
group, only one adenoma occurred at 36 weeks in 17 rats, while in the low exposure group, no liver tumor occurred in 23 rats. Thus, these findings document nonlinearities for some of the effects of AAF, with supralinear effects at the high exposure for cell proliferation and induction of HAF, and a no-observed-effect level for induction of promotable liver neoplasms at the lowest cumulative exposure of 0.126 mmol/kg, in spite of the formation of DNA adducts. We conclude that the effects of this DNA-reactive hepatocarcinogen leading to initiation exhibit nonlinearities and possible thresholds. C 1998 Society of Toxicotogy.
2-Acetylaminofluorene (AAF)
2 and diethylnitrosamine (DEN) are DNA-reactive rat liver hepatocarcinogens which have been extensively studied (Verna et ai, 1996a, b) . We have been investigating the dose response for early events leading to initiation of hepatocarcinogenesis by these agents (Umemura et ai, 1993; Williams et ai, 1993 Williams et ai, , 1996 . Experiments in rats of quantitative exposure responses for the early effects of these carcinogens using precise exposures in ranges in which effects other than DNA reactivity may influence the process have revealed nonlinearities for formation of liver DNA adducts, cytotoxicity, cell proliferation, initiation of carcinogenesis, and tumor formation, similar to findings with JV-nitrosomorpholine (Weber and Bannasch, 1994; Enzmann et ai, 1995) and aflatoxin B, (Root et ai, 1997) . Our findings document that an enhancement of initiation and carcinogenicity occurs at exposures that produce toxicity and compensatory cell proliferation, probably reflecting the fixation of DNA lesions as mutations, during DNA replication.
In the present experiment, we have extended our exposure response investigations on initiation of hepatocarcinogenesis by AAF (Umemura et ai, 1993; Stenback et ai, 1994 ) using a phenobarbital (PB) tumor promoting stimulus to assess initiating effects of even lower level exposures than previously studied (Williams et ai, 1993) . AAF was given as doses per unit body weight by gavage to assure " 500 ppm of phenobarbital in the diet for 24 weeks, following 12 weeks of either olive oil or three different doses of AAF, administered daily by gavage. fc GST-P + , RF (replicating fraction), and H&E histology were conducted. c GST-P, RF, and H&E histology were conducted. d GST-P, RF, H&E, GS, DNA adduct and arylsulfotransferase monitoring were conducted. ' GST-P, RF, and H&E histology were conducted. f All deaths were not related to exposure; the three unscheduled deaths occurred during the first 12 weeks.
precise dosimetry, as in a previous study (Umemura et ai, 1993) . Several early effects of AAF, such as DNA adduct formation, cell toxicity, and cell proliferation, were measured under conditions which can be assumed to represent at least minimal effects. With these qualifications, we report here that in a study design of low-level, repeat, precise exposures over a narrow (10-fold) range, possible nonlinearities of some initial effects and tumorigenicity of AAF were evident and that the lowest exposure was nontumorigenic in spite of adduct formation. The findings suggest that these nonlinearities and lack of tumorigenicity may be a consequence of the absence, at the low exposure, of certain cellular effects, such as cell proliferation, which contribute to initiation of carcinogenesis.
MATERIALS AND METHODS

Animals
A total of 135 male Fischer F344 (F344) rats was obtained from Charles River Laboratory (Kingston, NY) at 6 weeks of age and held for 2 weeks of quarantine. At the start of the study, rats were 8 ± 1 weeks of age and weighed 130 ± 10 g. The rats were housed in a conventional animal facility. They were kept in groups of six in solid-bottom polycarbonate cages with heat-treated hardwood chip bedding (Beta-Chips, Northeastern Product Corp., Warrenburg, NY) in a room maintained at 20 ± 2°C, at 50 ± 10% relative humidity with a 12-h dark and low light cycle from 7 PM to 7 AM. The basal diet NIH-07 was given ad libitum and water from the Westchester County water supply was provided by a stainless steel distribution system. The facility was accredited by the American Association for the Accreditation of Laboratory Animal Care and the care of the animals conformed to the Guide for the Care and Use of Laboratory Animals . The facility operated under the supervision of an Institutional Animal Care and Utilization Committee, which approved this study.
Chemicals and Exposure
AAF was obtained from Sigma Chemical Co. (St. Louis, MO) and its purity was analyzed by the Instrument Facility of the American Health Foundation, using a reverse-phase Hypersil HPLC column and an isocratic acetonitrilewater solvent system. The AAF purity was found to be greater than 99%. The dosing solutions were prepared by dissolving AAF in olive oil (Bertolli Inc., Italy). PB was obtained from Sigma Chemical Co. and incorporated into the diet at 0 05% by BioServ (Frenchtown, NJ).
The rats were divided into four groups. The number per group, doses, frequency of administration, and duration of exposure are shown in Table 1 . AAF was instilled intragastrically daily (in the morning) in 5 mi/kg for all groups for up to 12 weeks, at concentrations of 66.9 (low), 223 (mid), or 669 (high) ^tg/ml. One day after the last exposure at 4, 8, and 12 weeks, six rats were killed. After the 12-week initiation period, animals were maintained for 24-week promotion on the PB diet. At all terminations, rats were killed by decapitation under carbon dioxide anesthesia, between 9 AM and 2 PM.
Measurement of DNA Adducts
DNA isolation from rat liver. To measure DNA adducts, frozen samples of rat liver were homogenized and, after pronase and RNase digestions, DNA was isolated using 500/G Qiagen columns (Qiagen Inc, Chatsworth, CA). The RNase was heat denatured before use. A Beckman DU 640 spectrophotometer was used for DNA quantitation measuring 230/260/280 ratios using the DNA/ Oligo Quant software. The 260/280 ratios > 1.8 and 260/230 ratios > 1.5 were considered acceptable. 32 Ppostlabeling. The postJabeling method was based upon that developed by Reddy and Randerath (1986 were washed prior to use. Twenty microliters (10 fi\ X2) of DNA sample mixture was removed for analysis using a multidirectional TLC. Three microliters of the remaining labeled DNA mixture was diluted to 300 fii with 20 mM CHES, pH 9.5. Two 5-/J.1 aliquots of this were resolved using the solvent for normal nucleotides together with samples from the dAp-spiked incubation. The following solvents were used: 2.3 M sodium phosphate, pH 5.5 (Dl direction); 3.3 M lithium formate/7.0 M urea, pH 3.5 ± 0.01 (D3 direction); 0.8 M lithium chloride, 0.33 M Tris-HCl, 5.3 M urea, pH 8.0 ± 0.01 (D4 direction); and 0.28 M ammonium sulfate/50 mM sodium phosphate, pH 6.6 ± 0.01 (normal nucleotides).
After separation of the adducts and normal nucleotides, the washed and dried plates were quantitated for radioactivity using a GS 250 Bio-Rad Molecular Imager (Hercules, CA). Data were collected for 5 min for normal nucleotides and 20 min for adducts at 200 nm resolution. Radioactive areas were men quantitated using the Molecular Imager software and data exported to a spreadsheet for calculation of adduct/10 9 bases. A standard curve over the adduct range gave a linear slope (r 2 = 0.988).
In addition, a comparison was made between the nuclease P, and butanol (Gupta, 1985) enhancements.
Arylsulfotransferase (AST) assay. AST activities were determined at 12 weeks as described by Mulder et al. (1977) and Ringer (1987) . The liver homogenates were centrifuged at 9000g for 20 min to remove nuclei, lysosomes, and mitochondria, and the supematants were then centrifuged at 100,000g for 60 min to sediment the microsomes. The postmicrosomal supernatant was used as the source of AST. Protein was determined using the bicinchonic acid kit (Pierce, Rockford, IL). Bovine serum albumin was used as standard. Absorbance at 405 nm of a 0.5-ml reaction mixture containing 100 mM Tris (pH 8.0), 10 mM p-nitrophenylsulfate (Sigma), 20 yM 3',5'-adenosine diphosphosulfate (Sigma), 0.55 mM N-hydroxy-AAF (NO Chemical Carcinogen Reference Standard Repository), 5% (v/v) ethanol, and 300 fig protein was monitored at room temperature for 10 min with a Beckman DU 640 spectrophotometer using the kinetics program. The rate of p-nitrophenol formation in control incubation mixtures, lacking /V-OH-AAF, was subtracted from values for experimental mixtures to give a measure of JV-OH-AAF AST activity. The rate of sulfation was calculated from the amount of /Miitrophenol released using a molar extinction coefficient of 17,500 M~' cm" 1 (at pH 8.0). AST activity is expressed as nmol/mg/min.
Histopathological Examination
Standard slices were taken from each lobe of the liver . For routine histological examination, liver slices were fixed in 10% neutral buffered Formalin (NBF), embedded in paraffin, and processed for hematoxylin and eosin (H & E) staining.
Hepatocellular altered foci (HAF) and neoplasms were classified according to standard criteria (Stewart et al, 1980; Williams, 1980) .
Glutamine Synthetase Immunohistochemistry
Sections from livers, fixed in 3.5% paraformaldehyde, were deparaffinized and treated with 0.5% hydrogen peroxide in methanol to inactivate endogenous peroxidase and then used for the immunohistochemical localization of glutamine synthetase (GS), as previously described (Burger et aL, 1989; Gebhardt et aL, 1989) . For the analysis of the normal distribution of GS, the GS + areas encircling central veins and the perimeter of the corresponding venule were determined. These values were used to calculate the ratio between the respective GS + area and the perimeter of the corresponding vessel, the relative mean width (RMW), which provides a measure of the GS + zone independent of the cutting plane of the vessel (Gebhardt and Williams, 1995) .
PCNA Immunohistochemistry
To assess cell proliferation, separate liver sections were fixed in NBF, cut, and stained for proliferating cell nuclear antigen (PCNA) (Galand and Degraef, 1989; Dietrich, 1993) . The quantitation of PCNA-positive hepatocellular nuclei in the immunostained sections was performed in the following manner a square graticule (Olympus Instruments, Inc., Cherry Hill, NJ) with 25 equal subdivisions was used for quantitating labeled cells at 200X magnification. Each side of the graticule was confirmed by measurement with a second micrometer (Graticules, Ltd., Tonbridge, UK) as 0.125 mm, providing a square counting area that usually contained between 50 to 100 hepatocytes. All PCNA-positive nuclei in this graticule area were counted. Counts were obtained for each animal from 25 graticule squares taken along the length of one to three liver lobe sections on single glass slide. From the 25 graticule areas enumerated for each animal, between 1900 and 2200 nuclei per liver slide were counted. Based on the above, the replicating fraction (RF) represents the percentage of PCNA-positive nuclei per hepatocellular nuclei counted.
Glutathione S-Transferase Placental Form Immunohistochemistry
For identification of foci of cells expressing the placental form of glutathione S-transferase (GST-P) activity (Sato et al, 1984) , the liver sections were processed for immunohistochemical staining. Anti-GST-P antibody was obtained from Upstate Biotechnology, Inc. (Lake Placid, NY). Sections were stained by the avidin-biotin-peroxidase complex method (van der Loos el al, 1987) .
Quantification of Hepatocellular Altered Foci
GST-P + HAF were quantified using a microscope equipped with a drawing attachment, a Videoplan electronic visual digitizing system (Carl Zeiss, Thornwood, NY) as previously described . Values are given as average/cm 2 of liver area ± standard deviation.
Statistical Methods
For continuous outcome measures of GS + , GST-P + foci, and RF (PCNA), experimental group means (1.5, 5, and 15 /unol/kg body wt AAF) were compared against the control mean at each termination point (weeks 4, 8, 12, and 36) using a one-way analysis of variance (ANOVA) followed by Dunnett's method for multiple comparisons, which is a very powerful post-hoc test (Dunnett, 1955) . In addition, the mean outcome levels (GST-P + foci and RF) were compared among the four termination times (weeks 4, 8, 12, and 36) at each dose level using one-way ANOVA followed by Tukey's multiple comparison procedure (Fleiss, 1986) . To assess possible nonlinear dose-response association, ordinary least squares regression analysis was used, fitting the outcome level versus AAF dose and AAF dose-squared terms; significant overall model fit (Overall F) significant (p < 0.05) dose-squared terms are reported. Similarly for liver tumor incidence, overall differences among the four groups at the two termination points (weeks 12, 36) were determined by the Pearson x 1 statistic followed by pairwise comparisons of each dose group with control, adjusted for multiple comparisons (Gabriel, 1966) . For incidence trend analysis, the Cochran-Armitage test was performed, and departure from linearity tested (Fleiss, 1981) . GST-P + foci and RF levels were compared between tumor and nontumor bearing animals using unpaired t test.
RESULTS
Several hepatic effects in rats were studied for three doses of AAF over a 10-fold range selected on the basis of a previous study (Umemura et al, 1993) . Doses were given as daily intragastric instillations for up to 12 weeks yielding cumulative exposures of 0.126, 0.42, and 1.26 mmol/kg body weight for Analysis of arylsulfotransferase activity in rat liver cytosol after 12 weeks of exposure to AAF. The assay used jV-hydroxy-2-acetylaminofluorene as the acceptor substrate and p-nitrophenylsulfate as donor and followed the release of p-nitrophenol anion. At the highest dose there was a significant (p < 0.05) inhibition compared to control values. the low exposure (LE), mid exposure (ME), and high exposure (HE), respectively (Table 1) .
All exposures to AAF produced DNA adducts at 12 weeks. A single major adduct was observed together with some minor components (Fig. 1) . The level of adducts significantly (p < 0.05) increased at all exposures, although at the HE the level plateaued (Fig. 2) . In one sample, a comparison between the nuclease P, and butanol enhancement procedures revealed equivalent results (data not shown).
To examine whether activation of AAF was altered by the exposures, liver arylsulfotransferase activity was measured. As shown in Fig. 3 , at 12 weeks, a significantly reduced level compared to control was evident in the HE group. The LE was not reduced and the ME group showed a lower value, but this was not significantly reduced, due to the wide range in the control group. The ME group, however, showed significant (p < 0.05) reduction compared to the LE group and, therefore, is considered reduced. This effect in the two top exposure groups is supported by observation on cytotoxicity (see below).
To quantify cytotoxicity, the area of the centrilobular GS + zone was measured at the end of exposures for 12 weeks. The GS + zone was 89%of control area in the LE, 78% in the ME, and 58% in the HE (Table 2 ). The reduction was significant only in the HE, but showed a significant trend (r = 0.50, p < 0.001). Cell injury was not evident by conventional microscopy. Cell proliferation of nonlesional hepatocytes was quantified at 4, 8, 12, and 36 weeks. The RF of control rats remained constant at about 1 over the initial 12 weeks (Table 3 ; Fig. 4) . At 4 weeks, the RF of hepatocytes was increased in only the HE group by about 2-fold over controls. At 8 weeks, the RF was further increased in the HE group, now by about 10-fold over controls, while the LE and ME groups still showed no ; and high dose ) followed by administration to all groups of PB for 24 weeks. The response increased with dose. Only the highest dose showed a significant spike in the replicating fraction. Significance and trend analysis are shown in Table 4. increase. At 12 weeks, there was no further increase in the HE group and the other groups still did not show an increase, although there appeared to be a tendency to increase in the ME group. Over time, the values in the HE group at 8 and 12 weeks were significantly increased compared to that at 4 weeks. This was not the case with the other groups. At 36 weeks, after 24 weeks of PB administration, the RFs of the control, LE and ME groups were about doubled compared to the levels at 12 weeks, but only the exposed groups were significantly increased. In the HE group, the RF was significantly diminished compared to 12 week levels, but remained higher than the values of the other exposed groups (Table 3 ; Fig. 4 ).
Histopathologic evaluation of the H & E-stained liver sections revealed predominantly clear and acidophilic cell HAF by 8 weeks. In addition, there were some mixed or basophilic cell foci. Quantification of lesion multiplicity was done only on GST-P + HAF. At 4 weeks, GST-P + HAF were not found in controls, but were present in all other groups, although without dose relationship and not significantly increased (Table 4) . At the 8-week termination interval, HAF were clearly increased in the HE group, but not in the two lower exposure groups, although there was a positive trend. At the end of AAF exposure at 12 weeks, the multiplicities of HAF were now substantially increased in the HE group, about 176-fold over controls. The value for the LE group remained constant, and the ME group exhibited a further tendency to increase, with a positive trend. At 12 weeks, when the LE and ME groups were separately compared with respect to the mean GST-P + HAF over time (4, 8, and 12 weeks), the difference was not significant, whereas, the HE group increase overtime was significant (p < 0.05) ( Table 4 ; Fig. 5 ). At 36 weeks, after 24 weeks of PB administration, HAF were not increased in the two lower dose groups compared to controls, while the HE group remained at about the same multiplicity as at 12 weeks. The overall GST-P multiplicity of the HE group compared to the other two exposures at 8, 12, and 36 weeks showed a significant (p < 0.05) nonlinearity. given daily for 12 weeks and followed by exposure of all groups to PB in the diet for 24 weeks. At all three time intervals after initiation of dosing the differences between low and mid exposures were not significant, whereas the differences between these and the high exposure were, at p < 0.001 (control ; low dose ; mid dose ; and high dose ).
At the end of AAF exposure at 12 weeks, a 50% incidence of hepatocellular adenomas was present in the HE group, while no tumors were found in the other groups (Table 5) . At 36 weeks, after 24 weeks of PB administration, the HE group exhibited adenomas (64%) or carcinomas (36%). In the ME group, one animal had an adenoma, yielding a 5% incidence. No tumors were found in 23 rats in the LE group. At 36 weeks, the multiplicity and size of adenomas was also increased over the 12-week interval (Table 5) . Namely, at 12 weeks there were 0.5 adenomas per HE rat with an average size of 0.29 cm 2 , while at 36 weeks, the average number of adenomas per HE animal was 0.64 and a size of 0.65 cm 2 . In the ME group, at 36 weeks there was only 1 adenoma, bringing the average number of adenomas per rat to 0.06. All neoplasms were GST-P + . Moreover, at weeks 12 and 36, animals with adenomas had higher GST-P + and RF values than those without tumors. In animals with carcinomas, however, only the GST-P + values were higher. The percentage of incidence of both hepatocellular adenomas and carcinomas at 36 weeks showed an apparent nonlinearity (Fig. 6) . Examination of other organs and tissues did not reveal any neoplasia.
DISCUSSION
In this experiment, we measured the exposure response effects of AAF over a 10-fold cumulative exposure range of 0.126 to 1.26 mmol total/per kg body weight, to extend our previous observation of nonlinearity between 0.5 and 2.0 mmol/kg for several effects leading to initiation of hepatocarcinogenesis (Umemura et ai, 1993) . The findings confirm and extend those of our previous report. Note. All values without a footnote indicate lack of statistical significance. " After 12 weeks of AAF administration (daily gavage), PB at 500 ppm was given in the diet for 24 weeks. b p < 0.001 using adjusted x 2 test c p < 0.001, Cochran-Armitage test (with combined adenomas and carcinomas) and nonsignificant linear departure.
All exposures to AAF produced DNA adducts, measured at 12 weeks. The nuclease P, enhancement of the 32 P postlabeling procedure was found to be suitable for these samples, although it has been reported to give poor and variable yields with AAF (Phillips et al., 1993) . The P, and butanol (data not shown) enhancement methods were compared and found to yield one major adduct, which was chromatographically similar. The difference between our study and those of others is that we used repeat exposures which may lead to accumulation of nuclease P,-stable adducts, probably N 2 adducts (Gupta, 1988) . Adducts that accumulate are potentially more significant for initiation of carcinogenesis because they provide a greater opportunity for mutations if they are stable miscoding lesions (Shibutani and Grollman, 1993) . The level of adducts plateaued at the HE, similar to findings by Poirier et al. (1984; Poirier and Beland, 1994 ) that C-8 DNA adducts, measured by 0.00 0.42 0.84
1.26
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FIG. 6. Percentage of incidence of animals with hepatocellular adenomas and carcinomas at 36 weeks after exposure to AAF for 12 weeks and followed for 24 weeks with PB. An apparent nonlinearity of the curve is evident a specific radioimmunoassay, plateaued by 2-3 weeks in Wistar-Furth rats given 0.02% AAF in the diet or BALB/c mice administered 30 or 150 mg/kg/day. One basis for the plateau in our experiment may be the large number of HAF present at this time in the HE group. These foci do not activate AAF (Williams et al., 1976 ) and hence do not accumulate adducts, thereby diluting the average level in the liver, as we have previously noted (Umemura et al, 1993) . Another factor is inhibition of AST activity, which was measured in the liver cell cytosol. Previous reports, at doses greater than seven times the present HE of AAF, reported inhibition of this enzyme (Ringer and Norton, 1987) . In the present study, inhibition occurred with the top two exposures. A paired comparison of DNA adduct levels and AST activity showed them to be significantly negatively correlated (r = -0.69, p < 0.01), which might be expected since this enzyme is critical in the metabolic activation of AAF (Miller, 1994) . Recently, Root et al. (1997) have reported that with single doses of aflatoxin B,, the DNA adducts levels were directly proportional to dose, but when dosing was repeated, after the 10th AFB dose, the adducts were much lower at the higher doses than after a single administration. As with our findings, this could also reflect inhibition of bioactivation by repeat exposures. Inhibition of bioactivation may be a consequence of general cytotoxicity or, more specifically, substrates that form reactive metabolites act as suicide substrates for the enzymes involved in their bioactivation.
Assessment of centrilobular toxicity, as measured by depletion of the centrilobular GS zone which is a sensitive measure of toxicity (Gebhardt and Williams, 1995) , revealed that the HE was markedly cytotoxic, while the ME produced moderate toxicity according to a trend test and the LE did not produce significant toxicity. A transient effect at the LE cannot be excluded, but this exposure also did not enhance cell proliferation. In the ME and HE groups, centrilobular cytotoxicity was dose related, whereas cell proliferation was not statistically increased in the ME group, but was elevated in the HE group. The average level of adducts in the HE group was not greater than that in the ME group, but as noted above, that may reflect dilution of the levels present in hepatocytes by HAF and inhibition of AST activity. Nevertheless, cytotoxicity in the HE group was only about two-fold greater than in the ME and thus, reparative cell proliferation appears to be a very sensitive response to cell injury. These findings again demonstrate that cytoxicity, which was not apparent in conventional histologic preparations, led to reparative cell proliferation, which increased disproportionately to exposure. Some mechanisms for hepatotoxicity of AAF have been described by Neumann et al. (1997) , albeit at higher exposures (-fourfold) than the highest used here.
HAF were induced only by the HE to AAF, first at 8 weeks and then further increased at 12 weeks. This 8-week exposure to 0.84 mmol/kg, which induced 3.02 HAF/cm 2 , is slightly greater than the 0.5 mmol/kg used in a previous study which induced only 0.81 HAF/cm 2 (Umemura et al, 1993) . Thus, it appears that cumulative exposures between 0.5 and 1.26 mmol/ kg, the HE in this study which induced 19.35 HAF/cm 2 , appear to be in a range in which supralinearity is expressed. Moreover, below this range, in the LE and ME groups, even at the maximum cumulative exposures of 0.13 and 0.42 mmol/kg body weight, respectively, and after PB administration, no definite increase in HAF occurred. This indicates that the level of adducts, i.e., about 50 per 10 9 in the LE, was not sufficient to initiate carcinogenesis, as manifested by GST-P + foci, in the absence of increased cell proliferation. This may be due to the fact that there is a high level of background endogenous DNA alteration in normal cells (about 1 in 10 8 ) (Randerath et al, 1993) and thus minor chemical-induced increments are not of biological significance (Nestmann et al, 1996) . It would be interesting to determine whether such exposures lead to other genetic effects in the liver as has been reported for heterocyclic amines (Sawada et al, 1994) . Also, the multiplicity of HAF in the HE group at 12 weeks was about 18-fold greater than that in the ME, although adduct levels in HE animals were about the same as the ME (Fig. 2) , again bearing in mind the probable dilution of overall adduct levels in hepatocytes in the HE group by the lesser contributing HAF cells. This disproportionate induction of HAF could once more reflect the contribution of cell proliferation to their formation. The importance of increased levels of cell proliferation in hepatocarcinogenesis was established by Craddock (1971) and Warwick (1971) from studies demonstrating that partial hepatectomy enhanced chemical-induced hepatocarcinogenesis. Numerous subsequent studies have documented enhancement of HAF formation by induction of cell proliferation (Hirota et al, 1982; Ying et al, 1982; Tanaka et al, 1986) . The basis for such enhancement probably resides in the reduced opportunity for repair of DNA damage before the cell replicates its DNA, as also demonstrated by the enhancing effect of cell proliferation on the mutagenic effects of DNA-reactive chemicals in cultured liver cells (Berman et al, 1978; Tong et al, 1980) . Other investigators have described a "promoting" effect of AAF in liver carcinogenesis at much higher doses than those used here (about 4-to 10-fold) (Saeter et al, 1988; Neumann et al, 1997) , but have not reported on levels of cell proliferation, which could also contribute to neoplastic development (Williams, 1981 (Williams, , 1992 .
The tumor promoting stimulus of PB was used to manifest initiation as tumor formation, as in previous studies (Williams et al, , 1996 . With the HE, PB elicited a 100% incidence of tumors. The HE group received 3.35 mg/kg/day for 12 weeks in comparison to an exposure in a previous study of about 2.5 mg/kg/day resulting from 50 ppm in the diet, for 76 weeks, which produced 100% liver cancer (Williams et al, 1991) . Thus, PB for 24 weeks after 12 weeks after this exposure to AAF results in about the same effect as feeding the carcinogen at the same level for 76 weeks. Moreover, the induction of HAF by 12 weeks or less, as seen here, clearly indicates potential carcinogenic activity as previously reported (Williams, 1982) .
With PB administration for promotion, HAF in controls were increased compared to the multiplicity present at 12 weeks, which could represent a trophic effect of PB on cryptogenic foci, as previously described (Williams et al, , 1996 . The multiplicities were also increased in the LE and ME groups, but not in the HE group, probably because of the large number of HAF already present at the end of AAF exposure. No tumors occurred in the control or LE group, indicating that the multiplicities of HAF of 0.11 and 0.14 per cm 2 , respectively, at the time of commencement of promotion did not provide a sufficient substrate of initiation for tumor promotion. In the ME group, the finding in 17 rats of only 1 tumor, emanating from 1.03 HAF/cm 2 , strengthens the conclusion that the absence of tumors in 23 rats in the LE group with about 1/1 Oth the multiplicity of induced HAF truly represents a no-effect level for initiation. Assuming a linear dose-response between cumulative AAF exposure and tumor incidence, a 10% incidence would be expected at the LE based on observing a 0% incidence at dose 0 and a 100% incidence at the HE. In fact, no tumor (0%) was observed at the LE. Although the assumption of a linear dose-response relationship between cumulative AAF exposure and tumor incidence (Fig. 6 ) failed to be rejected in Table 5 {p = 0.11), a significant nonlinear result in the Cochran-Armitage test would have occurred (p = 0.05) had there been no tumor in 20 animals instead of 9 in the control group. In fact, we can be 92% certain (upper confidence limit of 0 events of 23 trials; Jovanovic and Levy, 1997 ) that the underlying (or true) tumor incidence at LE is less than what is expected under a linear dose-response model (i.e., 10%). In the HE group, the incidence of tumors that developed from 19.35 HAF/cm 2 was 100% versus about 5% in the ME group, demonstrating an increase markedly disproportionate to the threefold greater cumulative exposure and the negligible increase in the level of DNA adducts in the HE group. This further establishes the enhancement of initiation by compensatory cell proliferation, which was significant only in the HE group.
An additional point of interest in the effect of PB on the ME group is that extrapolation of the number of foci in crosssectional area, i.e., 1.03 cm 2 , to the large number that would likely be present in whole liver Campbell et al., 1982) permits the conclusion that in the 17 rats that were promoted, the 1 neoplasm arose from a collective incidence of at least several thousand foci. Thus, HAF with the requisite alterations for promotability to neoplasm formation are rare, as previously described Williams et al, 1996) .
The present study further extends our previous reports (Umemura et al., 1993; Williams et al, 1993 Williams et al, , 1996 and those of others (Enzmann et al., 1995; Root et al, 1997 ) that initiation of hepatocarcinogenesis under conditions of lowlevel exposure appears to be nonlinear (Fig. 6) . In this experiment, we used young adult male rats of the F344 strain and, accordingly, the findings can be interpreted only for these specific conditions. In the model, the supralinearity observed for the carcinogenicity of AAF in the HE is suggested to represent an enhancement of the consequences of AAF modification of DNA produced by compensatory cell replication elicited by cytotoxicity at high exposures. Effects at exposures that produce such sensitizing effects, i.e., cytotoxicity and increased cell proliferation, cannot be quantitatively extrapolated to lower potential exposures that do not. Moreover, in this experiment we have used intragastric instillation for exact dose delivery, which may produce a greater effect than other dose rates because of a bolus effect (La et al., 1996) . These findings demonstrate that different mechanisms underlie effects of carcinogens at low and high toxic exposures, as has been discussed by Counts and Goodman (1995) .
The findings from the present experiment document nonlinearities for some of the AAF effects and a no-observedeffect level for induction of promotable liver neoplasia at the lowest cumulative exposure of 0.126 mmol/kg, in spite of formation of DNA adducts. We, therefore, conclude that the effects of this DNA-reactive hepatocarcinogen demonstrate apparent nonlinearities and thresholds. Accordingly, we suggest, as previously (Williams et al., , 1996 that quantitative risk assessment for extrapolation to humans must be better supported by information on cellular effects that have been observed in experimental studies over the exposure range of interest. For exposure of humans to environmental carcinogens, this would be even lower than that studied here and only intermittent. Thus, high-dose continuous exposure rodent studies are suggested to yield overestimates of risk.
